Case no. | Age/sex | Interval | Diagnosis | EBV positivity | Symptoms except lymphoadenopathy | Treatment | Outcome | Reference |
---|---|---|---|---|---|---|---|---|
1 | 64 years/M | 5 years and 5 months from transplant | monomorphic PTLD | − | Fever, abdominal pain | Reduction of immunosupression, rituximab, 90Y-IT | * | Current case |
1 year from the 1st PTLD | cHL PTLD | − | Fever | Surgery | CR | |||
2 | 28 years/F | 2 years and 2 months from transplant | Polymorphic PTLD | + | Fever | Reduction of immunosupression, acyclovir | CR | 15 |
2 years and 5 months from the 1st PTLD | cHL PTLD | + | Fever, splenomegaly | Reduction of immunosupression, acyclovir, MOPP, splenectomy | CR | |||
3 | 9 years/M | 8 years from transplant | Polymorphic PTLD | + | Enlarged tonsil, adenoid | Reduction of immunosupression, acyclovir | CR | 12 |
6 years and 10 months from the 1st PTLD | cHL PTLD | + | Mediastinal mass | COPP, ABV | CR | |||
4 | 6 years/M | 4 years and 2 months from transplant | Polymorphic PTLD | + | None | Reduction of immunosupression, gancyclovir | CR | 14 |
1 year and 6 months from the 1st PTLD | cHL PTLD | + | Fever | MOPP, ABVD, radiation | CR |